Mean serum D-dimer level to predict in-hospital mortality in COVID-19
- PMID: 34468611
- DOI: 10.1590/1806-9282.20200896
Mean serum D-dimer level to predict in-hospital mortality in COVID-19
Abstract
Objective: The prognostic effect of the mean serum D-dimer levels, which was calculated from the first five days of hospitalization of the patients, has not been elucidated. This study aimed to evaluate the effect of mean D-dimer level about in-hospital mortality in patients hospitalized due to coronavirus disease-2019 (COVID-19) infection.
Methods: In this observational retrospective study, we examined the in-hospital prognostic value of mean D-dimer [D-dimerfirst day+D-dimerthird day+D-dimerfifth day)/3 on 240 consecutive adult patients with COVID-19. Patients were stratified into tertiles according to their mean D-dimer starting from the lowest one. In-hospital mortality rates were compared between tertiles and the power of the mean D-dimer level was also presented by a receiver operating curve analysis.
Results: After adjustment for confounding baseline variables, mean D-dimer in tertile 3 was associated with 4.2-fold hazard ratio of in-hospital mortality (odds ratio [OR] 4.2; 95% confidence interval [CI] 1.8-20.1, p<0.001). A receiver-operating curve analysis revealed that the optimal cutoff value of the mean D-dimer to predict in-hospital mortality was 779 μg/L with 77% sensitivity and 83% specificity (area under the curve [AUC] 0.87; 95%CI 0.81-0.94; p<0.001).
Conclusion: Patients with a higher mean D-dimer level should be followed-up more closely as they may be a candidate for a more aggressive treatment modality, such as biologic agents or convalescent plasma.
Similar articles
-
D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19.PLoS One. 2021 Aug 26;16(8):e0256744. doi: 10.1371/journal.pone.0256744. eCollection 2021. PLoS One. 2021. PMID: 34437642 Free PMC article.
-
Elevated levels of D-dimer in patients with COVID-19: prognosis value.Pan Afr Med J. 2020 Jul 7;35(Suppl 2):105. doi: 10.11604/pamj.supp.2020.35.2.24692. eCollection 2020. Pan Afr Med J. 2020. PMID: 33282060 Free PMC article.
-
Role of interleukin-6, serum ferritin, and d-dimer in hospitalized COVID-19 patients.Cytokine. 2024 Dec;184:156776. doi: 10.1016/j.cyto.2024.156776. Epub 2024 Oct 8. Cytokine. 2024. PMID: 39383646
-
Relationship of D-dimer with severity and mortality in SARS-CoV-2 patients : A meta-analysis.Int J Lab Hematol. 2021 Feb;43(1):110-115. doi: 10.1111/ijlh.13336. Epub 2020 Sep 15. Int J Lab Hematol. 2021. PMID: 32931146
-
D-dimer, disease severity, and deaths (3D-study) in patients with COVID-19: a systematic review and meta-analysis of 100 studies.Sci Rep. 2021 Nov 8;11(1):21888. doi: 10.1038/s41598-021-01462-5. Sci Rep. 2021. PMID: 34750495 Free PMC article.
Cited by
-
High myoglobin level as an independent risk factor for death in elderly patients with critical COVID-19 infection: a retrospective case-control study.BMC Infect Dis. 2024 Aug 20;24(1):842. doi: 10.1186/s12879-024-09621-5. BMC Infect Dis. 2024. PMID: 39164612 Free PMC article.
-
Use of hydroxychloroquine and azithromycin combination to treat the COVID-19 infection.World J Exp Med. 2022 May 20;12(3):44-52. doi: 10.5493/wjem.v12.i3.44. eCollection 2022 May 20. World J Exp Med. 2022. PMID: 35765514 Free PMC article. Review.
-
Serum sST2: key biomarkers in COVID-19 patients with implications for coronary artery disease.BMC Infect Dis. 2025 Apr 7;25(1):471. doi: 10.1186/s12879-025-10849-y. BMC Infect Dis. 2025. PMID: 40197291 Free PMC article.
-
Comment on: "Comparison of C-reactive protein and C-reactive protein-to-albumin ratio in predicting mortality among geriatric coronavirus disease 2019 patients".Rev Assoc Med Bras (1992). 2022 Jul;68(7):975-976. doi: 10.1590/1806-9282.20220386. Rev Assoc Med Bras (1992). 2022. PMID: 35946777 Free PMC article. No abstract available.
-
Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial.Stem Cell Res Ther. 2022 Mar 21;13(1):122. doi: 10.1186/s13287-022-02796-1. Stem Cell Res Ther. 2022. PMID: 35313959 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical